Q2 2019 13F Holders as of 30 Jun 2019
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
33,940,151
-
Total 13F shares
-
11,228,228
-
Share change
-
+11,228,168
-
Total reported value
-
$311,861,739
-
Price per share
-
$28.99
-
Number of holders
-
59
-
Value change
-
+$311,859,996
-
Number of buys
-
58
Institutional Holders of TransMedics Group, Inc. - Common Stock (TMDX) as of Q2 2019
As of 30 Jun 2019,
TransMedics Group, Inc. - Common Stock (TMDX) was held by
59 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
11,228,228 shares.
The largest 10 holders included
ABRAMS CAPITAL MANAGEMENT, L.P., FMR LLC, CREDIT SUISSE AG/, Zimmer Partners, LP, JANUS HENDERSON GROUP PLC, RTW INVESTMENTS, LP, MASSACHUSETTS FINANCIAL SERVICES CO /MA/, BlackRock Inc., VANGUARD GROUP INC, and EMERALD ADVISERS, LLC.
This page lists
59
institutional shareholders reporting positions in this security
for the Q2 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.